ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
Dow Jones
39.112,16
-0,76%
Euro vs US Dollar
1,071
-0,21%
Bitcoin
61.809,13
2,57%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Applied Molecular Transport Inc (AMTI)

  7. Applied Molecular Transport Inc (AMTI) News

AMTI

Applied Molecular Transp... (AMTI)

Applied Molecular Transport Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AMTI
DatumZeitQuelleÜberschriftSymbolFirma
09/01/202412h12Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:AMTIApplied Molecular Transport Inc
03/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202415h15Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202415h14Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202415h14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202415h13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202415h13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMTIApplied Molecular Transport Inc
28/12/202323h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
28/12/202323h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
28/12/202323h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
28/12/202323h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
28/12/202323h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
28/12/202323h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
27/12/202322h15Business WireCyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.NASDAQ:AMTIApplied Molecular Transport Inc
27/12/202321h49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMTIApplied Molecular Transport Inc
26/12/202323h27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMTIApplied Molecular Transport Inc
15/12/202322h06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMTIApplied Molecular Transport Inc
15/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMTIApplied Molecular Transport Inc
27/11/202322h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
27/11/202322h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
21/11/202315h16Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AMTIApplied Molecular Transport Inc
16/11/202323h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
09/11/202322h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AMTIApplied Molecular Transport Inc
09/11/202322h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMTIApplied Molecular Transport Inc
09/11/202322h01GlobeNewswire Inc.Applied Molecular Transport Reports Third Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
25/10/202322h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMTIApplied Molecular Transport Inc
10/10/202323h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
05/10/202301h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
05/10/202301h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
03/10/202301h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
 Showing the most relevant articles for your search:NASDAQ:AMTI

Kürzlich von Ihnen besucht

BIT
P1VUL2
NLBNPIT1VUL2 20991231 16...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten